Workdom Strategist

Cas-CLOVER gene editing of HEK293 cells: a Better Investment Than CRISPR For Commercial Gene Therapy and Vaccine Bioprocessing

By Workdom Strategist / November 8, 2021

Viruses equipped with natural abilities as vehicles of gene transfer,  promote host-viral co-evolution. For millions of years, the human immune system has been at war with all types of viruses and pathogens, resulting in new serotypes and mechanisms of gene transfer. Now viral vectors, such as adeno-associated virus (AAV) vectors can be engineered to deliver…

Read More

Precise Clonal Selection At Your Fingertips with GS-KO CHO Cells

By Workdom Strategist / October 27, 2021

As one of the world’s top industries, pharmaceutical companies bring in billions of dollars and save millions of lives. Time and money goes into the process of research and development, drug discovery, and bioprocessing; the necessary parts of getting drugs to market that have potential to save a life. Like with any business, cutting costs…

Read More

Targeted Gene Editing in Suspension CHO Cells for Cell Line Development Using the Cas-CLOVER™ Gene Editing System

By Workdom Strategist / September 21, 2021
Read More